Wafik El-Deiry: Delighted to visit with Bayer Pharmaceuticals in Boston
Wafik El-Deiry recently shared on LinkedIn:
“Delighted to visit with Bayer Pharmaceuticals in Boston for discussions and to give the Keynote ‘Serial Entrepreneurship in Cancer Drug Development: Ongoing Lessons’ at the one-year anniversary event this afternoon. There are great opportunities in this ecosystem.
I wanted to thank Fiona Mack, Alberto Nobili, and Friedemann Janus for the invitation and the hospitality during the visit. Love the Co.Lab swag.
Now on the way to the ASCO24.”
Source: Wafik El-Deiry/LinkedIn
Wafik El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School Director of the Legorreta Cancer Center at Brown University, and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals.
Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry made important contributions in cell death signaling and our understanding of the sensitivity of tumors to chemotherapy. El-Deiry has more than 400 peer-reviewed publications and 5 edited books.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023